5000 employees
Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug Conjugate
2002
Syntarga B.V. raised undisclosed on November 28, 2010
Investors: Participatiemaatschappij Oost Nederland NV